
How dantrolene binds and closes a calcium channel in malignant hyperthermia
Researchers have identified where the drug dantrolene binds on RyR1, the calcium-release channel involved in malignant hyperthermia. The findings show that dantrolene works together with ATP or ADP to trigger a structural change linked to closing the channel.













